Abstract:Background Systemic sclerosis (SSc) is a chronic inflammatory disease with complex pathogenesis. The role of regulatory T cells (Tregs) in the development of SSc has started being studied during the last decade with new aspects being disclosed continuously. Although there is a general agreement in the medical literature regarding the decreased functional capacity of circulating Tregs in SSc, the alteration of absolute number of Treg and Th17 cells as well as their associations with clinical characteristics of SSc are still unclear. Objectives The aim of the present study was to explore the relationship between absolute reduction of peripheral CD4 +regulatory T and Th17 cell subset and clinical characteristics in SSc patients. Methods The peripheral CD4 +T subsets from 54 patients with SSc and 30 healthy control subjects were analysed. The patients were divided into the untreated group (n=29) and treated group (n=25). The patients were also divided into group 1 (n=9) for the prominent pulmonary lesions, group 2 (n=5) for prominent esophageal involvement, group 3 (n=8) for both lung lesions and esophageal involvement, and group 4 (n=10) who had fingers swelling, sclerosis, ulceration prominent. Directly using the results from flow cytometry combined with internal standard beads, absolute number of peripheral Th17 and Treg cells from the subjects in each group were calculated. Results Although there were some changes among CD4 +T cell subsets in peripheral blood from these SSc patients, the major alteration was the reductions of Treg cell absolute number. Compared with the normal controls, the number of CD4+CD25+FOXP3+Treg cells were significantly decreased in untreated group (p=0.029) , in group 1 (p=0.014) and in group 2 (p=0.073) as compared with heathy controls. Interestingly, Tregs in group 2 were significantly lower than those in group 1 (p=0.006), in group 3(p=0.098) and in group 4(p=0.034). In addition, the number of Th17 cells were significantly higher in group 3 (p=0.003 and 4 (p Conclusions The absolute number of peripheral CD4 +CD25+FOXP3+Treg cells decreased in untreated patients, indicating that this reduction arising from the disease itself. Our findings suggest that the severity of clinical manifestations in patients with SSc is related to the absolute decrease of peripheral Treg cells. Although there was no statistically significant different, absolute number of the Treg cells trended to decrease in patients who had more severe clinical manifestations. With the involvement of vital organs, the absolute number of Treg cells decreased more significantly. Moreover, in patients with relatively mild clinical manifestations, the increase in the absolute number of Th17 cells is even more obvious, suggesting that Th17 also plays an important role in early and intermediate stages. Disclosure of Interest None declared

The Elevated Expression of Th17-related Cytokines and Receptors is Associated with Skin Lesion Severity in Early Systemic Sclerosis.

Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus.

FRI0450 Associations of alterations of peripheral regulatory t and th17 absolute cell numbers with clinical features in patients with systemic sclerosis

Changes in peripheral T-lymphocyte subsets and serum cytokines in patients with systemic sclerosis

Increased Frequency of Th17 Cells in Systemic Sclerosis is Related to Disease Activity and Collagen Overproduction.

Relationships of Peripheral Blood Th17 and Regulatory T Cells with Disease Activity in Patients with Systemic Sclerosis

Expression of Th17 Cytokines in Skin Lesions of Patients with Psoriasis

IL-21 drives skin and lung inflammation and fibrosis in a model for systemic sclerosis

Skin Gene Expression Correlates of Severity of Interstitial Lung Disease in Systemic Sclerosis.

Elevated, Interleukin-21 expression is correlated with systemic sclerosis' severity in Tunisian patients

Th17 cell‐derived miR‐155‐5p modulates interleukin‐17 and suppressor of cytokines signaling 1 expression during the progression of systemic sclerosis

IL-17C Amplifies Epithelial Inflammation in Human Psoriasis and Atopic Eczema

Integration of Microrna and Mrna Expression Profiles in the Skin of Systemic Sclerosis Patients

Single-cell transcriptome analysis identifies skin-specific T-cell responses in systemic sclerosis

Expression of IL-17A in Involved Lesions and Blood Mononuclear Cells of Patients with Psoriaisis

Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis

Elevated Serum Levels of Interleukin-1Β and Interleukin-33 in Patients with Systemic Sclerosis in Chinese Population

Correlation of Interferon-Inducible Chemokine Plasma Levels with Disease Severity in Systemic Sclerosis

Expression and Pathogenic Analysis of Integrin Family Genes in Systemic Sclerosis

Elevated Levels of TL1A Are Associated with Disease Activity in Patients with Systemic Sclerosis.

Enhanced Innate and Acquired Immune Responses in Systemic Sclerosis Primary Peripheral Blood Mononuclear Cells (PBMCs)